好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Clinical and Electrophysiological Features of Chronic Inflammatory Demyelinating Polyneuropathy in Chile.
Neuromuscular and Clinical Neurophysiology (EMG)
P2 - Poster Session 2 (5:30 PM-6:30 PM)
12-006

To investigate the frequency of CIDP in south-eastern Santiago and to describe the clinical and electrophysiological characteristics of typical CIDP and subtypes in this population.

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-mediated neuropathy usually with insidious onset and with progressive symmetric or asymmetric polyneuropathy. CIDP has heterogeneous clinical features, classified as ‘typical’ CIDP or ‘atypical’ subtypes including multifocal acquired demyelinating sensory and motor neuropathy (MADSAM).

We reviewed the notes of 204 patients who consulted in Hospital del Salvador, between January-December 2017 and were registered as polyneuropathy, neuropathy, Guillain Barre or CIDP. We included all patients meeting the diagnostic criteria of the EFNS/PNS for definitive and possible CIDP. Data were collected using a data extraction protocol designed by the authors including demographic, clinical, laboratory and electrophysiological information. ‘Typical’ CIDP was defined as symmetric sensory and motor polyneuropathy involving proximal and distal, or proximal regions. The asymmetry of symptoms was used to define MADSAM.

The estimated prevalence and incidence of CIDP were 2.3/100.000 and 0.8/100.00 respectively. Fourteen patients (8 men, 6 women) were classified as definitive or possible CIDP, nine of whom had typical CIDP. The age of onset ranged from 16 to 68 years. Three patients also had diabetes mellitus. The average median and peroneal motor nerve conduction velocities were 33.9 m/s and 33.8 m/s respectively. The average number of conduction blocks per patient was 3.7. All patients had conduction blocks in an upper limb. Distal sensory action potentials were reduced or absent in nine patients. All patients were treated with prednisone, six patients with intravenous immunoglobulin. Four patients became worse after prednisone therapy.

The prevalence and incidence rates were similar to those reported in the Caucasian and Japanese populations and the clinical and physiological features seem to be similar across different races and geographic areas.

Authors/Disclosures
Jose G. Cea Munoz, MD (Universidad De Chile)
PRESENTER
No disclosure on file
Juan Francisco Idiaquez, Jr., MD (UHN) No disclosure on file
No disclosure on file
No disclosure on file
Roque Villagra, MD No disclosure on file
No disclosure on file